These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1723686)

  • 1. The presence of an M4 subtype muscarinic receptor in the bovine adrenal medulla revealed by mRNA and receptor binding analyses.
    Fernando JC; Abdallah EA; Evinger M; Forray C; el-Fakahany EE
    Eur J Pharmacol; 1991 Aug; 207(4):297-303. PubMed ID: 1723686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic cholinergic receptors in the rat caudate-putamen and olfactory tubercle belong predominantly to the m4 class: in situ hybridization and receptor autoradiography evidence.
    Vilaró MT; Wiederhold KH; Palacios JM; Mengod G
    Neuroscience; 1991; 40(1):159-67. PubMed ID: 2052149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
    Ferrari-Dileo G; Waelbroeck M; Mash DC; Flynn DD
    Mol Pharmacol; 1994 Dec; 46(6):1028-35. PubMed ID: 7808421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of muscarinic receptor subtypes in pig airways: radioligand binding and northern blotting studies.
    Haddad EB; Mak JC; Hislop A; Haworth SG; Barnes PJ
    Am J Physiol; 1994 Jun; 266(6 Pt 1):L642-8. PubMed ID: 8023952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
    Lazareno S; Buckley NJ; Roberts FF
    Mol Pharmacol; 1990 Dec; 38(6):805-15. PubMed ID: 2250662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD; Mash DC
    Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic receptor binding sites of the M4 subtype in porcine lung parenchyma.
    Chelala JL; Kilani A; Miller MJ; Martin RJ; Ernsberger P
    Pharmacol Toxicol; 1998 Nov; 83(5):200-7. PubMed ID: 9834968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
    Smith TD; Annis SJ; Ehlert FJ; Leslie FM
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1173-81. PubMed ID: 2005579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of muscarinic m3 receptor protein and M3 receptor binding in rat brain.
    Levey AI; Edmunds SM; Heilman CJ; Desmond TJ; Frey KA
    Neuroscience; 1994 Nov; 63(1):207-21. PubMed ID: 7898649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain.
    Waelbroeck M; Tastenoy M; Camus J; Christophe J
    Mol Pharmacol; 1990 Aug; 38(2):267-73. PubMed ID: 2385234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of muscarinic acetylcholine binding sites in human and bovine cerebral microvessels.
    Linville DG; Hamel E
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):179-86. PubMed ID: 7477441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
    Buckley NJ; Bonner TI; Buckley CM; Brann MR
    Mol Pharmacol; 1989 Apr; 35(4):469-76. PubMed ID: 2704370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands.
    Hu J; Wang SZ; Forray C; el-Fakahany EE
    Mol Pharmacol; 1992 Aug; 42(2):311-21. PubMed ID: 1513329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
    Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites.
    Delmendo RE; Michel AD; Whiting RL
    Br J Pharmacol; 1989 Feb; 96(2):457-64. PubMed ID: 2924085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding properties of nine 4-diphenyl-acetoxy-N-methyl-piperidine (4-DAMP) analogues to M1, M2, M3 and putative M4 muscarinic receptor subtypes.
    Waelbroeck M; Camus J; Tastenoy M; Christophe J
    Br J Pharmacol; 1992 Jan; 105(1):97-102. PubMed ID: 1596694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic receptors in canine colonic circular smooth muscle. I. Coexistence of M2 and M3 subtypes.
    Zhang LB; Horowitz B; Buxton IL
    Mol Pharmacol; 1991 Dec; 40(6):943-51. PubMed ID: 1758444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.